229 related articles for article (PubMed ID: 12546224)
1. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
2. An update on the discrepancy between calculated and measured neutron-induced radioactivity levels in Hiroshima.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):345-56. PubMed ID: 12546223
[TBL] [Abstract][Full Text] [Related]
3. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
4. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
[TBL] [Abstract][Full Text] [Related]
5. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
Rühm W; Walsh L; Chomentowski M
Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
[TBL] [Abstract][Full Text] [Related]
6. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
Little MP
Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
[TBL] [Abstract][Full Text] [Related]
7. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
8. Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.
Preston DL; Pierce DA; Shimizu Y; Cullings HM; Fujita S; Funamoto S; Kodama K
Radiat Res; 2004 Oct; 162(4):377-89. PubMed ID: 15447045
[TBL] [Abstract][Full Text] [Related]
9. Risk coefficient for gamma-rays with regard to solid cancer.
Kellerer AM; Walsh L; Nekolla EA
Radiat Environ Biophys; 2002 Jun; 41(2):113-23. PubMed ID: 12201054
[TBL] [Abstract][Full Text] [Related]
10. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
Rühm W; Walsh L
Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156
[TBL] [Abstract][Full Text] [Related]
11. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
Otake M; Schull WJ
Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
[TBL] [Abstract][Full Text] [Related]
12. The effects of neutrons in Hiroshima. Implications for the risk estimates.
Kellerer AM
C R Acad Sci III; 1999; 322(2-3):229-37. PubMed ID: 10196677
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a neutron RBE of 70 (+/- 50) for solid-tumor induction at Hiroshima and Nagasaki and its implications for assessing the effective neutron quality factor.
Zaider M
Health Phys; 1991 Nov; 61(5):631-6. PubMed ID: 1752746
[TBL] [Abstract][Full Text] [Related]
14. Neutron discrepancies in the DS86 Hiroshima dosimetry system.
Straume T; Egbert SD; Woolson WA; Finkel RC; Kubik PW; Gove HE; Sharma P; Hoshi M
Health Phys; 1992 Oct; 63(4):421-6. PubMed ID: 1526783
[TBL] [Abstract][Full Text] [Related]
15. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
16. Accounting for neutron exposure in the Japanese atomic bomb survivors.
Cullings HM; Pierce DA; Kellerer AM
Radiat Res; 2014 Dec; 182(6):587-98. PubMed ID: 25409123
[TBL] [Abstract][Full Text] [Related]
17. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
Preston DL; Pierce DA
Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
[TBL] [Abstract][Full Text] [Related]
18. Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.
Walsh L
Radiat Environ Biophys; 2013 Mar; 52(1):29-36. PubMed ID: 23161400
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the DS86 atomic bomb radiation dosimetry methods using data on severe epilation.
Stram DO; Mizuno S
Radiat Res; 1989 Jan; 117(1):93-113. PubMed ID: 2913611
[TBL] [Abstract][Full Text] [Related]
20. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Radiation cataract.
Otake M; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():283-93. PubMed ID: 1762117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
